Suppr超能文献

凝血因子 XIII 在血栓形成中的新认知作用

Newly-Recognized Roles of Factor XIII in Thrombosis.

作者信息

Byrnes James R, Wolberg Alisa S

机构信息

Department of Pathology and Laboratory Medicine, McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

出版信息

Semin Thromb Hemost. 2016 Jun;42(4):445-54. doi: 10.1055/s-0036-1571343. Epub 2016 Apr 7.

Abstract

Arterial and venous thromboses are major contributors to coagulation-associated morbidity and mortality. Greater understanding of mechanisms leading to thrombus formation and stability is expected to lead to improved treatment strategies. Factor XIII (FXIII) is a transglutaminase found in plasma and platelets. During thrombosis, activated FXIII cross-links fibrin and promotes thrombus stability. Recent studies have provided new information about FXIII activity during coagulation and its effects on clot composition and function. These findings reveal newly-recognized roles for FXIII in thrombosis. Herein, we review published literature on FXIII biology and effects on fibrin structure and stability, epidemiologic data associating FXIII with thrombosis, and evidence from animal models indicating FXIII has an essential role in determining thrombus stability, composition, and size.

摘要

动脉和静脉血栓形成是导致凝血相关发病率和死亡率的主要因素。对导致血栓形成和稳定性的机制有更深入的了解有望带来更好的治疗策略。凝血因子 XIII(FXIII)是一种存在于血浆和血小板中的转谷氨酰胺酶。在血栓形成过程中,活化的 FXIII 使纤维蛋白交联并促进血栓稳定性。最近的研究提供了关于 FXIII 在凝血过程中的活性及其对凝块组成和功能影响的新信息。这些发现揭示了 FXIII 在血栓形成中新认识到的作用。在此,我们综述了已发表的关于 FXIII 生物学及其对纤维蛋白结构和稳定性影响的文献、将 FXIII 与血栓形成相关联的流行病学数据,以及来自动物模型的证据,表明 FXIII 在决定血栓稳定性、组成和大小方面具有重要作用。

相似文献

1
Newly-Recognized Roles of Factor XIII in Thrombosis.
Semin Thromb Hemost. 2016 Jun;42(4):445-54. doi: 10.1055/s-0036-1571343. Epub 2016 Apr 7.
2
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.
Blood Adv. 2018 Jan 3;2(1):25-35. doi: 10.1182/bloodadvances.2017011890. eCollection 2018 Jan 9.
3
Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.
Int J Mol Sci. 2021 Feb 5;22(4):1607. doi: 10.3390/ijms22041607.
4
Factor XIII activity mediates red blood cell retention in venous thrombi.
J Clin Invest. 2014 Aug;124(8):3590-600. doi: 10.1172/JCI75386. Epub 2014 Jul 1.
5
Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis.
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):308-16. doi: 10.1161/ATVBAHA.115.306695. Epub 2016 Jan 7.
6
Fibrinogen, red blood cells, and factor XIII in venous thrombosis.
J Thromb Haemost. 2015 Jun;13 Suppl 1(Suppl 1):S208-15. doi: 10.1111/jth.12918.
7
Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
Biochim Biophys Acta Proteins Proteom. 2017 Oct;1865(10):1246-1254. doi: 10.1016/j.bbapap.2017.07.001. Epub 2017 Jul 4.
8
Factor XIII, clot structure, thrombosis.
Thromb Res. 2012 Mar;129(3):382-7. doi: 10.1016/j.thromres.2011.11.040. Epub 2011 Dec 24.
9
Genetic landscape in coagulation factor XIII associated defects - Advances in coagulation and beyond.
Blood Rev. 2023 May;59:101032. doi: 10.1016/j.blre.2022.101032. Epub 2022 Nov 2.
10
Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.
Arterioscler Thromb Vasc Biol. 2022 Aug;42(8):931-941. doi: 10.1161/ATVBAHA.122.317164. Epub 2022 Jun 2.

引用本文的文献

1
Understanding blood clot mechanical stability: the role of factor XIIIa-mediated fibrin crosslinking in rupture resistance.
Res Pract Thromb Haemost. 2025 Apr 25;9(4):102871. doi: 10.1016/j.rpth.2025.102871. eCollection 2025 May.
3
Another cryo-EM success: structure of FXIII.
Blood. 2025 Jan 23;145(4):356-357. doi: 10.1182/blood.2024027405.
7
Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke.
Biomedicines. 2024 Feb 22;12(3):497. doi: 10.3390/biomedicines12030497.
8
Thrombotic Disease in Hemophilic Patients: Is This a Paradox in a State of Hypocoagulability?
Diagnostics (Basel). 2024 Jan 29;14(3):286. doi: 10.3390/diagnostics14030286.
9
Coagulation factor XIII is a critical driver of liver regeneration after partial hepatectomy.
J Thromb Haemost. 2024 Mar;22(3):620-632. doi: 10.1016/j.jtha.2023.11.008. Epub 2023 Nov 24.
10
Fibrinogen and fibrin: synthesis, structure, and function in health and disease.
J Thromb Haemost. 2023 Nov;21(11):3005-3015. doi: 10.1016/j.jtha.2023.08.014. Epub 2023 Aug 23.

本文引用的文献

1
Venous thrombosis.
Nat Rev Dis Primers. 2015 May 7;1:15006. doi: 10.1038/nrdp.2015.6.
2
Factor XIII: Structure and Function.
Semin Thromb Hemost. 2016 Jun;42(4):422-8. doi: 10.1055/s-0036-1571341. Epub 2016 Mar 28.
3
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.
J Thromb Haemost. 2016 Jan;14(1):143-52. doi: 10.1111/jth.13182. Epub 2016 Jan 4.
4
Protein Disulfide Isomerase in Thrombosis.
Semin Thromb Hemost. 2015 Oct;41(7):765-73. doi: 10.1055/s-0035-1564047. Epub 2015 Sep 26.
5
Coagulation factor XIIIa is inactivated by plasmin.
Blood. 2015 Nov 12;126(20):2329-37. doi: 10.1182/blood-2015-07-650713. Epub 2015 Sep 10.
6
Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.
Blood. 2015 Oct 15;126(16):1940-8. doi: 10.1182/blood-2015-06-652263. Epub 2015 Aug 31.
7
Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women.
J Thromb Haemost. 2015 Sep;13(9):1568-75. doi: 10.1111/jth.13045. Epub 2015 Aug 21.
8
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker?
Thromb Haemost. 2015 Jul;114(1):123-32. doi: 10.1160/TH14-11-0952. Epub 2015 May 7.
9
Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes.
Circ Res. 2015 Jul 3;117(2):157-65. doi: 10.1161/CIRCRESAHA.117.305784. Epub 2015 May 5.
10
Cystamine preparations exhibit anticoagulant activity.
PLoS One. 2015 Apr 27;10(4):e0124448. doi: 10.1371/journal.pone.0124448. eCollection 2015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验